Hsbc Holdings PLC reduced its position in Innophos Holdings, Inc. (NASDAQ:IPHS) by 12.2% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 43,751 shares of the specialty chemicals company’s stock after selling 6,090 shares during the quarter. Hsbc Holdings PLC’s holdings in Innophos were worth $1,759,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently made changes to their positions in IPHS. Thomson Horstmann & Bryant Inc. grew its stake in shares of Innophos by 8.4% during the 1st quarter. Thomson Horstmann & Bryant Inc. now owns 20,366 shares of the specialty chemicals company’s stock worth $818,000 after purchasing an additional 1,570 shares during the period. GHP Investment Advisors Inc. grew its stake in shares of Innophos by 22.8% during the 4th quarter. GHP Investment Advisors Inc. now owns 9,081 shares of the specialty chemicals company’s stock worth $424,000 after purchasing an additional 1,689 shares during the period. Swiss National Bank grew its stake in shares of Innophos by 6.3% during the 1st quarter. Swiss National Bank now owns 34,000 shares of the specialty chemicals company’s stock worth $1,367,000 after purchasing an additional 2,000 shares during the period. Ramsey Quantitative Systems acquired a new position in shares of Innophos during the 4th quarter worth $134,000. Finally, California Public Employees Retirement System grew its stake in shares of Innophos by 6.3% during the 4th quarter. California Public Employees Retirement System now owns 52,208 shares of the specialty chemicals company’s stock worth $2,440,000 after purchasing an additional 3,108 shares during the period. 95.27% of the stock is currently owned by institutional investors.
Innophos opened at $48.67 on Wednesday, Marketbeat reports. Innophos Holdings, Inc. has a 52 week low of $38.66 and a 52 week high of $51.34. The company has a debt-to-equity ratio of 1.03, a quick ratio of 1.70 and a current ratio of 3.22. The stock has a market capitalization of $959.44 million, a P/E ratio of 19.78 and a beta of 0.83.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 5th. Investors of record on Friday, May 18th were given a $0.48 dividend. The ex-dividend date of this dividend was Thursday, May 17th. This represents a $1.92 annualized dividend and a dividend yield of 3.94%. Innophos’s dividend payout ratio is presently 78.05%.
A number of equities analysts have recently weighed in on the stock. BidaskClub raised shares of Innophos from a “hold” rating to a “buy” rating in a research note on Wednesday, June 6th. TheStreet raised shares of Innophos from a “c+” rating to a “b” rating in a research note on Wednesday, May 30th. Finally, Zacks Investment Research raised shares of Innophos from a “hold” rating to a “buy” rating and set a $51.00 price target on the stock in a research note on Wednesday, May 9th.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Want to see what other hedge funds are holding IPHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innophos Holdings, Inc. (NASDAQ:IPHS).
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.